A New Executive Order on Drug Pricing: Is the U.S. Finally Catching Up?
Introduction The U.S. government has taken a bold policy step that could significantly impact the pharmaceutical landscape: a new Executive Order proposes tying Medicare drug prices to those paid in other developed nations. This model, commonly referred to as the “Most Favored Nation” (MFN) pricing approach, is designed to bring American prescription costs closer to […]
A New Executive Order on Drug Pricing: Is the U.S. Finally Catching Up? Read More »